Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NEULAND LABS vs GSK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NEULAND LABS GSK PHARMA NEULAND LABS/
GSK PHARMA
 
P/E (TTM) x 24.9 62.1 40.1% View Chart
P/BV x 7.9 18.8 42.1% View Chart
Dividend Yield % 0.2 1.7 9.8%  

Financials

 NEULAND LABS   GSK PHARMA
EQUITY SHARE DATA
    NEULAND LABS
Mar-23
GSK PHARMA
Mar-23
NEULAND LABS/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs2,0041,684 119.0%   
Low Rs9661,231 78.5%   
Sales per share (Unadj.) Rs928.4191.9 483.7%  
Earnings per share (Unadj.) Rs127.435.9 355.3%  
Cash flow per share (Unadj.) Rs168.639.8 424.1%  
Dividends per share (Unadj.) Rs10.0032.00 31.3%  
Avg Dividend yield %0.72.2 30.7%  
Book value per share (Unadj.) Rs774.8102.9 753.1%  
Shares outstanding (eoy) m12.83169.41 7.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.67.6 21.1%   
Avg P/E ratio x11.740.6 28.7%  
P/CF ratio (eoy) x8.836.7 24.0%  
Price / Book Value ratio x1.914.2 13.5%  
Dividend payout %7.889.2 8.8%   
Avg Mkt Cap Rs m19,052246,858 7.7%   
No. of employees `000NANA-   
Total wages/salary Rs m2,0185,950 33.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m11,91232,517 36.6%  
Other income Rs m971,007 9.7%   
Total revenues Rs m12,00933,524 35.8%   
Gross profit Rs m2,7188,033 33.8%  
Depreciation Rs m528658 80.2%   
Interest Rs m13118 721.1%   
Profit before tax Rs m2,1578,364 25.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5222,288 22.8%   
Profit after tax Rs m1,6356,076 26.9%  
Gross profit margin %22.824.7 92.4%  
Effective tax rate %24.227.4 88.5%   
Net profit margin %13.718.7 73.5%  
BALANCE SHEET DATA
Current assets Rs m7,60924,943 30.5%   
Current liabilities Rs m4,39013,264 33.1%   
Net working cap to sales %27.035.9 75.2%  
Current ratio x1.71.9 92.2%  
Inventory Days Days697 6.5%  
Debtors Days Days1,109216 513.3%  
Net fixed assets Rs m8,1896,988 117.2%   
Share capital Rs m1291,694 7.6%   
"Free" reserves Rs m9,81215,735 62.4%   
Net worth Rs m9,94117,430 57.0%   
Long term debt Rs m7420-   
Total assets Rs m15,79831,930 49.5%  
Interest coverage x17.5462.6 3.8%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.81.0 74.0%   
Return on assets %11.219.1 58.6%  
Return on equity %16.434.9 47.2%  
Return on capital %21.448.1 44.5%  
Exports to sales %73.50-   
Imports to sales %15.148.1 31.5%   
Exports (fob) Rs m8,750NA-   
Imports (cif) Rs m1,80415,630 11.5%   
Fx inflow Rs m8,7501,622 539.6%   
Fx outflow Rs m1,80415,630 11.5%   
Net fx Rs m6,946-14,008 -49.6%   
CASH FLOW
From Operations Rs m2,3724,842 49.0%  
From Investments Rs m-6158,079 -7.6%  
From Financial Activity Rs m-1,358-15,433 8.8%  
Net Cashflow Rs m403-2,512 -16.1%  

Share Holding

Indian Promoters % 32.8 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 29.1 11.6 251.5%  
FIIs % 22.7 2.9 774.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 67.2 25.0 268.8%  
Shareholders   27,723 114,663 24.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NEULAND LABS With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on NEULAND LABS vs GSK Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

NEULAND LABS vs GSK Pharma Share Price Performance

Period NEULAND LABS GSK Pharma S&P BSE HEALTHCARE
1-Day -3.14% 3.05% 1.18%
1-Month -13.36% -9.96% -0.75%
1-Year 262.37% 52.31% 61.82%
3-Year CAGR 42.83% 10.81% 18.16%
5-Year CAGR 58.61% 8.40% 19.79%

* Compound Annual Growth Rate

Here are more details on the NEULAND LABS share price and the GSK Pharma share price.

Moving on to shareholding structures...

The promoters of NEULAND LABS hold a 32.8% stake in the company. In case of GSK Pharma the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of NEULAND LABS and the shareholding pattern of GSK Pharma.

Finally, a word on dividends...

In the most recent financial year, NEULAND LABS paid a dividend of Rs 10.0 per share. This amounted to a Dividend Payout ratio of 7.8%.

GSK Pharma paid Rs 32.0, and its dividend payout ratio stood at 89.2%.

You may visit here to review the dividend history of NEULAND LABS, and the dividend history of GSK Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.